HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance.

AbstractOBJECTIVE:
This study explored the importance of glycemic burden compared with features of the metabolic syndrome in the pathogenesis of diabetic neuropathy by comparing C-fiber function in people with type 1 diabetes to that in people with impaired glucose tolerance (IGT).
RESEARCH DESIGN AND METHODS:
The axon reflex-elicited flare areas (LDIflares) were measured with a laser Doppler imager (LDI) in age-, height-, and BMI-matched groups with IGT (n = 14) and type 1 diabetes (n = 16) and in healthy control subjects (n = 16).
RESULTS:
The flare area was reduced in the IGT group compared with the control (2.78 +/- 1.1 vs. 5.23 +/- 1.7 cm(2), P = 0.0001) and type 1 diabetic (5.16 +/- 2.3 cm(2), P = 0.002) groups, whereas the flare area was similar in the type 1 diabetic and control groups.
CONCLUSIONS:
This technique suggests that small-fiber neuropathy is a feature of IGT. The absence of similar small-fiber neuropathy in those with longstanding type 1 diabetes suggests that glycemia may not be the major determinant of small-fiber neuropathy in IGT.
AuthorsAlistair Q Green, Singhan Krishnan, Francis M Finucane, Gerry Rayman
JournalDiabetes care (Diabetes Care) Vol. 33 Issue 1 Pg. 174-6 (Jan 2010) ISSN: 1935-5548 [Electronic] United States
PMID20040675 (Publication Type: Journal Article)
Topics
  • Adult
  • Case-Control Studies
  • Diabetic Neuropathies (physiopathology)
  • Diagnostic Techniques, Neurological
  • Female
  • Glucose Intolerance (physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Nerve Fibers, Unmyelinated (parasitology, pathology)
  • Peripheral Nervous System Diseases (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: